Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics

References

• Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Panes J, Beaugerie L, Kragiannis J. Allez M, et al. for the European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7–27.
   PubMed Web of Science ®Google Scholar
• Vind I, Riis L, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274–82.
   PubMed Web of Science ®Google Scholar
• Manninen P, Karvonen A-L, Huhtala H, Rasmussen M, Collin P. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol 2010;45:1063–7.
   PubMed Web of Science ®Google Scholar
• Jussila A, Virta LJ, Kautiainen H, Rekiaro M, Nieminen U, Färkkilä MA. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis 2012;18:555–61.
   PubMed Web of Science ®Google Scholar
• Ward FM, Bodger K, Daly MJ, Heatley RV. Clinical economics review: medical management of inflammatory bowel disease. Aliment Pharmacol Ther 1999;13:15–25.
   PubMedGoogle Scholar
• Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004;53:1471–8.
   PubMed Web of Science ®Google Scholar
• Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study. Inflamm Bowel Dis 2008;14:53–60.
   PubMedGoogle Scholar
• Prenzler A, Bokemeyer B, von der Schulenburg J-M, Mittendorf T. Health care costs and their predictors of inflammatory bowel diseases in Germany. Eur J Health Econ 2011;12:273–83.
   PubMed Web of Science ®Google Scholar
• Ebinger M, Leidl R, Thomas S, von Tirpitz C, Reinshagen M, Adler G, Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 2004;19:192–9.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Roine RP, Turunen U, Färkkilä MA, Arkkila PET. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis 2011;5:41–7.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PET. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 2009;18:961–9.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Roine RP, Sintonen H, Turunen U, Färkkilä MA, Arkkila PET. Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument. Qual Life Res 2010;19:919–28.
   PubMed Web of Science ®Google Scholar
• Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 2002;29:511–15.
   PubMed Web of Science ®Google Scholar
• ATC/DDD Index 2011. 2012. http://www.whocc.no/atc_ddd_index/. Accessed 17 June 2012.
   Google Scholar
• Statistics Finland. Cost-of-living index 2009. 2010. http://www.stat.fi/til/khi/2009/khi_2009_2010-01-15_tau_001.html. Accessed 1 August 2012.
   Google Scholar
• Sintonen H. The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. Melbourne: National Centre for Health Program Evaluation, Working Paper 41; 1994. http://www.buseco.monash.edu.au/centres/che/pubs/wp41.pdf. Accessed 1 August 2012.
   Google Scholar
• Guyatt G, Mitchell A, Irvine EJ, Singer J, Willians N, Goodacre R, A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804–10.
   PubMed Web of Science ®Google Scholar
• Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver diseases. Gut 2000;47:444–54.
   PubMed Web of Science ®Google Scholar
• Pallis AG, Mouzas IA, Vlachonikolis IG. The Inflammatory Bowel Disease Questionnaire: a review of its national validation studies. Inflamm Bowel Dis 2004;10:261–9.
   PubMed Web of Science ®Google Scholar
• Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011;106:741–7.
   PubMed Web of Science ®Google Scholar
• Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med 2009;122:599–604.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Blanchard JF, Bernstei CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133–42.
   PubMed Web of Science ®Google Scholar
• Feagins LA, Cryer BL. Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease? Dig Dis Sci 2010;55:226–32.
   PubMedGoogle Scholar
• Brakenhoff LK, van der Heijde DM, Hommes DW, Huizinga TW, Fidder HH. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis 2010;4:257–68.
   PubMed Web of Science ®Google Scholar
• Palm O, Bernklev T, Moum B, Gran JT. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 2005;32:1755–9.
   PubMed Web of Science ®Google Scholar
• Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci 2008;53:1020–4.
   PubMed Web of Science ®Google Scholar
• Cerveny P, Bortlik M, Kubena A, Vlcek J, Lakatos PL, Lukas M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007;13:1244–9.
   PubMed Web of Science ®Google Scholar
• Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994;106:287–96.
   PubMed Web of Science ®Google Scholar
• Casellas F, López-Vivancos J, Casado A, Malagelada J-R. Factors affecting health-related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002;11:775–81.
   PubMed Web of Science ®Google Scholar
• Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2003;15:1011–20.
   PubMed Web of Science ®Google Scholar
• Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006;131:719–28.
   PubMed Web of Science ®Google Scholar